missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Galunisertib

Descripción
Galunisertib is an ALK4 and ALK5 (TGFβRI) inhibitor (IC50 values are 77.7 and 172 nM, respectively). Also inhibits a range of other kinases with submicromolar IC50s including MINK, TGFβRII, ALK6 and ACVR2B. Inhibits TGFβ-induced SMAD phosphorylation in cancer cell lines in vitro and in vivo. Also reverses TGFβ-mediated suppression of T cell proliferation. Prevents TGFβ-mediated EMT and cell migration in vitro and exhibits antitumor efficacy in vivo. Used as component of growth media for urothelial organoids. Orally bioavailable.
Specifications
Specifications
| Nombre del producto químico o material | 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4 H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide |
| CAS | 700874-72-2 |
| Cantidad | 5 mg |
| Objetivo | TGF-beta Receptor Inhibitors |
| Fórmula molecular | C22H19N5O |
| Formula Weight (peso de la fórmula) | 369.43 |
| Tipo de producto | Inhibitor |
| Pureza | 98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?